Evidence map›Paper›PMID 26403707›Full record

ArticleImmunologic research2016

Interaction of TIM4 and TIM3 induces T helper 1 cell apoptosis.

Rong-Ti Ge, Lu Zeng, Li-Hua Mo, Ling-Zhi Xu, Huan-Ping Zhang, Hai-Qiong Yu, Min Zhang, Zhi-Gang Liu, Zhan-Ju Liu, Ping-Chang Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Defective efferocytosis in diabetes: molecular mechanisms and emerging therapeutic strategies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Tim-4 in Health and Disease: Friend or Foe?Frontiers in immunology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Rong-Ti GeDepartment of Gastroenterology, The Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, China.
Lu ZengShenzhen Key Laboratory of Allergy and Immunology, The Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China.
Li-Hua MoShenzhen Key Laboratory of Allergy and Immunology, The Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China.
Ling-Zhi XuShenzhen Key Laboratory of Allergy and Immunology, The Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China.
Huan-Ping ZhangDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, L8N 4A6, Canada.
Hai-Qiong YuShenzhen Key Laboratory of Allergy and Immunology, The Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China.
Min ZhangDepartment of Respirology, The First Affiliated Hospital, Shenzhen University, Shenzhen, China.
Zhi-Gang LiuShenzhen Key Laboratory of Allergy and Immunology, The Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China. lzg@szu.edu.cn.
Zhan-Ju LiuDepartment of Gastroenterology, The Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, China.
Ping-Chang YangShenzhen Key Laboratory of Allergy and Immunology, The Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China. pcy2356@163.com.
Shenzhen University · CNMcMaster University · CAShanghai Tenth People's Hospital · CNTongji University · CN

Funding

Canadian Institutes of Health Research 191063Canadian Institutes of Health Research 220058
6 · The paper itself

Abstract

The T helper 1 (Th1) polarization plays a critical role in the pathogenesis of a number of inflammatory disorders in the body; the remedies in the correction of polarized Th1 cells are limited. This study aims to investigate the role of T cell immunoglobulin mucin domain molecule 4 (TIM4) in the induction of Th1 cell apoptosis. In this study, polarized Th1 cells were generated from naive Th1 cells from the mouse spleen. Recombinant TIM4 was added to the culture to stimulate the polarized Th1 cells. The apoptosis of Th1 cells was assessed by flow cytometry. The expression of FasL was analyzed by chromatin immunoprecipitation, real time RT-PCR, and Western blotting. The results showed that the polarized Th1 cells expressed high levels of TIM3. After exposure of the polarized Th1 cells to TIM4 in the culture, a complex of TIM3 and TIM4 was detected on the surface of Th1 cells, which induced the Th1 cell apoptosis. The engagement of TIM3 by TIM4 increased p300 phosphorylation in Th1 cells, which further increased the levels of Fas ligand in the cells and induced Th1 cell apoptosis. In conclusion, TIM4 binds TIM3 on the surface of polarized Th1 cells to induce Th1 cell apoptosis, which may contribute to the development of Th2-dominant immune disorders.

Indexed as

ApoptosisAnimalsCell DifferentiationE1A-Associated p300 ProteinFas Ligand ProteinHepatitis A Virus Cellular Receptor 2MaleMembrane ProteinsMicePhosphorylationProtein BindingTh1 CellsTh2 CellsE1A-Associated p300 ProteinFas Ligand ProteinHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2Membrane ProteinsTIMD4 protein, humanApoptosisFasLT helper 1 cellTIM3TIM4

Identifiers

PMID26403707
OpenAlexW2130085957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.